These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7866327

  • 1. [Moraxella catarrhalis as an important etiologic factor in infection of the lower bronchial tree].
    Nowak-Sadzikowska J, Heczko PB.
    Pneumonol Alergol Pol; 1994; 62(9-10):530-2. PubMed ID: 7866327
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A, Janicka G, Krawiecka D, Kochanowska J.
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [Abstract] [Full Text] [Related]

  • 3. Branhamella catarrhalis infections.
    Wright PW, Avery WG.
    Am Fam Physician; 1989 Feb; 39(2):125-8. PubMed ID: 2492736
    [Abstract] [Full Text] [Related]

  • 4. Moraxella (Branhamella) catarrhalis.
    Verghese A, Berk SL.
    Infect Dis Clin North Am; 1991 Sep; 5(3):523-38. PubMed ID: 1955698
    [Abstract] [Full Text] [Related]

  • 5. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.
    Babay HA.
    Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364
    [Abstract] [Full Text] [Related]

  • 6. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC, McKenzie H.
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [Abstract] [Full Text] [Related]

  • 7. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F, Lambert-Zechovsky N, Bingen E.
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [Abstract] [Full Text] [Related]

  • 8. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K, Chang BJ, Mee BJ, Riley TV.
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [Abstract] [Full Text] [Related]

  • 9. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993.
    Nissinen A, Grönroos P, Huovinen P, Herva E, Katila ML, Klaukka T, Kontiainen S, Liimatainen O, Oinonen S, Mäkelä PH.
    Clin Infect Dis; 1995 Nov; 21(5):1193-6. PubMed ID: 8589142
    [Abstract] [Full Text] [Related]

  • 10. [Infections caused by Branhamella catarrhalis].
    Ejlertsen T, Schønheyder H.
    Ugeskr Laeger; 1990 Feb 12; 152(7):475-7. PubMed ID: 2106743
    [Abstract] [Full Text] [Related]

  • 11. [Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].
    Radzuweit S, Kalich R.
    Z Erkr Atmungsorgane; 1991 Feb 12; 177(1-2):82-7. PubMed ID: 1808857
    [Abstract] [Full Text] [Related]

  • 12. [Branhamella catarrhalis as a disease pathogen].
    Simon C.
    Fortschr Med; 1991 Jul 30; 109(22):447-8. PubMed ID: 1937324
    [Abstract] [Full Text] [Related]

  • 13. Ribotyping of strains of Moraxella (Branhamella) catarrhalis cultured from the nasopharynx and middle ear of children with otitis media.
    Brygge K, Sørensen CH, Colding H, Ejlertsen T, Højbjerg T, Bruun B.
    Acta Otolaryngol; 1998 Jun 30; 118(3):381-5. PubMed ID: 9655213
    [Abstract] [Full Text] [Related]

  • 14. [Moraxella (Branhamella) catarrhalis. A common pathogenic agent].
    Prost J, Scavizzi M.
    Presse Med; 1998 Jun 30; 22(16):779-82. PubMed ID: 8316533
    [Abstract] [Full Text] [Related]

  • 15. [Gram-negative coccus infection].
    Matsumoto K, Rikitomi N, Nagatake T, Kamruddin A.
    Nihon Rinsho; 1994 Feb 30; 52(2):367-71. PubMed ID: 8126887
    [Abstract] [Full Text] [Related]

  • 16. Significance of Haemophilus spp. and Branhamella catarrhalis in upper respiratory tract infections.
    Russo G, Stefani S, Oliveri S.
    J Chemother; 1991 Jan 30; 3 Suppl 1():15-8. PubMed ID: 12041752
    [Abstract] [Full Text] [Related]

  • 17. Moraxella catarrhalis bacteremia: a 10-year experience.
    Abuhammour WM, Abdel-Haq NM, Asmar BI, Dajani AS.
    South Med J; 1999 Nov 30; 92(11):1071-4. PubMed ID: 10586832
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia.
    Pingault NM, Bowman JM, Lehmann D, Riley TV.
    Pathology; 2010 Apr 30; 42(3):273-9. PubMed ID: 20350222
    [Abstract] [Full Text] [Related]

  • 19. [THE PATHOGENIC POTENTIAL OF MORAXELLA CATARRHALIS AND STAPHYLOCOCCUS EPIDERMIDIS UNDER INFLAMMATORY PROCESSES OF UPPER RESPIRATORY TRACTS].
    Kraeva LA, Burgasova OA, Kunilova ES, Petrova IS, Tseneva GY, Bespalova GL.
    Klin Lab Diagn; 2015 Nov 30; 60(11):58-61. PubMed ID: 26999868
    [Abstract] [Full Text] [Related]

  • 20. Molecular pathogenesis of infections caused by Moraxella catarrhalis in children.
    Bernhard S, Spaniol V, Aebi C.
    Swiss Med Wkly; 2012 Nov 30; 142():w13694. PubMed ID: 23136074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.